Postpartum blood pressure control may stop preeclampsia from leading to lifelong hypertension
NCT ID NCT06220721
First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time
Summary
This trial tests whether starting intensive blood pressure medication soon after childbirth can prevent chronic hypertension in women who had preeclampsia. Participants are randomly assigned to receive nifedipine ER when their blood pressure reaches different thresholds during the first six weeks after delivery. The study aims to see if tighter control can reverse blood vessel damage and lower the risk of future heart disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- a blood pressure medication called nifedipine ER (extended-release)
- What this could lead to
- If successful, this approach could prevent chronic hypertension and reduce long-term heart disease risk in women who had preeclampsia.
- What could go wrong
- This is a single study, and results may not apply to all women. Intensive blood pressure control may cause side effects like dizziness or low blood pressure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ECLAMPSIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Medical College of Wisconsin
RECRUITINGMilwaukee, Wisconsin, 53226, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
-
Northwestern University
RECRUITINGChicago, Illinois, 60611, United States
Contact Email: •••••@•••••
Contact
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Vitamin d may cut risk of repeat preeclampsia in High-Risk pregnancies
- Depression drug may mend blood vessels damaged by preeclampsia
- Genetic clues to severe preeclampsia could transform early detection
- New decision aid aims to cut heart disease risk in women after complicated pregnancies
- Could cocoa and veggies protect against pregnancy complications?
- Could High-Dose vitamin D3 shield pregnant women from preeclampsia?